Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01034670 · ClinicalTrials.gov registry record · NA
Advanced Gastrointestinal Endoscopic Imaging
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01034670: Clinical Trial NA study, sponsored by Stanford University.
NCT01034670 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01034670, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
To develop new methods to detect malignant and premalignant conditions of the gastrointestinal tract.
Primary Outcome
Detection of mucosa abnormailities as a first step in the goal of detection of neoplasia
Interventions
- DEVICE Dual axis endoscopic microscope
- DEVICE wide field fluorescence system
- DEVICE CellVizio
- DRUG fluorescent Peptide
- DRUG fluorescein
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2009-06 |
| Est. Completion | 2017-09-25 |
| Phase | NA |
Why NCT01034670 stopped before completion
NCT01034670 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 5 interventions - of which Dual axis endoscopic microscope is the first listed.
NCT01034670 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01034670 about?
NCT01034670 is a clinical study titled "Advanced Gastrointestinal Endoscopic Imaging". To develop new methods to detect malignant and premalignant conditions of the gastrointestinal tract.
What is the current status of trial NCT01034670?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2009-06. Estimated completion is 2017-09-25.
What interventions are being tested in trial NCT01034670?
The interventions under investigation include: Dual axis endoscopic microscope (DEVICE), wide field fluorescence system (DEVICE), CellVizio (DEVICE), fluorescent Peptide (DRUG), fluorescein (DRUG).
Who is sponsoring clinical trial NCT01034670?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01034670's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia